RT Journal Article SR Electronic T1 Role of Dopamine D1 and D2 Receptors in the Nucleus Accumbens in Mediating Reward JF The Journal of Neuroscience JO J. Neurosci. FD Society for Neuroscience SP 8580 OP 8587 DO 10.1523/JNEUROSCI.17-21-08580.1997 VO 17 IS 21 A1 Satoshi Ikemoto A1 Bradley S. Glazier A1 James M. Murphy A1 William J. McBride YR 1997 UL http://www.jneurosci.org/content/17/21/8580.abstract AB The objectives of this study were to examine the involvement of D1 and D2 receptors within the nucleus accumbens (ACB) in mediating reinforcement. The intracranial self-administration (ICSA) of D1 and D2agonists was used to determine whether activating D1 and/or D2 receptors within the ACB of Wistar rats is reinforcing. At concentrations of 0.25, 0.50, and 1.0 mm (25, 50, and 100 pmol/100 nl of infusion), neither the D1 agonistR(+)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol [SKF 38393 (SKF)] hydrochloride nor the D2 agonist (−)-quinpirole (Quin) hydrochloride was self-administered into the shell region of the ACB. On the other hand, equimolar mixtures of SKF and Quin (SKF+Quin), at concentrations of 0.25, 0.50, and 1.0 mm each, were significantly self-infused into the ACB shell. The core region of the ACB did not support the ICSA of SKF+Quin at any of these concentrations. Rats increased lever pressing when the response requirement was increased from a fixed ratio 1 (FR1) to FR3, and they responded significantly more on the infusion lever than they did on the control lever. Coadministration of either 0.50 mmR(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine (SCH 23390) hydrochloride, a D1 antagonist, or 0.50 mmS(−)-sulpiride, a D2antagonist, completely abolished the ICSA of the mixture of SKF+Quin (each at 0.50 mm) into the ACB shell. The present results suggest that concurrent activation of D1- and D2-type receptors in the shell of the ACB had a cooperative effect on DA-mediated reward processes.